Biorem Inc (BRM.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 11,253 | 9,431 | 4,730 | 9,315 | 14,886 |
| Cost of Goods | 8,087 | 6,881 | 3,621 | 7,718 | 9,864 |
| Gross Profit | 3,166 | 2,550 | 1,110 | 1,597 | 5,021 |
| Operating Expenses | 1,570 | 1,492 | 1,037 | 1,302 | 1,996 |
| Operating Income | 1,595 | 1,058 | 73 | 295 | 3,026 |
| Interest Expense | 38 | 41 | 44 | 47 | 47 |
| Other Income | 18 | -4 | 21 | -8 | 4 |
| Pre-tax Income | 1,575 | 1,013 | 51 | 240 | 2,982 |
| Income Tax | 417 | 269 | 13 | 69 | 790 |
| Net Income Continuous | 1,158 | 745 | 37 | 171 | 2,192 |
| Net Income | $1,158 | $745 | $37 | $171 | $2,192 |
| EPS Basic Total Ops | 0.07 | 0.05 | 0.00 | 0.01 | 0.14 |
| EPS Basic Continuous Ops | 0.07 | 0.05 | 0.00 | 0.01 | 0.14 |
| EPS Diluted Total Ops | 0.06 | 0.04 | 0.00 | 0.01 | 0.12 |
| EPS Diluted Continuous Ops | 0.06 | 0.04 | 0.00 | 0.01 | 0.12 |
| EBITDA(a) | $1,746 | $1,163 | $229 | $427 | $3,215 |